Fatal cytomegalovirus pneumonia in a patient receiving corticosteroids and methotrexate for mixed connective tissue disease

Southern Medical Journal

Volumn 89, Issue 7, 1996, Pages 726-728

  Wallace, John R ^a,b   Luchi, Michael ^a,b  

^a University of Kansas Medical Center ^*

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CONNECTIVE TISSUE DISEASE; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; MALE; VIRUS PNEUMONIA;

EID: 0030001347     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199607000-00016     Document Type: Article

References (17)

1. Meyers JD, Flournoy N, Thomas ED: Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153:478-488
2. Dowling JN, Saslow AR, Armstrong JA, et al: Cytomegalovirus infection in patients receiving immunosuppressive therapy tor rheumatologic disorders. J Infect Dis 1976; 133:399-408
3. Ho M, Dummer JS: Risk factors and approaches to infections in transplant recipients. Principles and Practice of Infectious Diseases. Mandell GL, Douglas RG, Bennett JE (eds). New York, Churchill-Livingstone Inc, 3rd Ed, 1990, p 2286
4. Drew WL: Cytomegalovirus infection in patients with AIDS Clin Infect Dis 1992; 14:608-615
5. Meyers JS: Infections in marrow transplant recipients. Principles and Practice of Infectious Diseases. Mandell GL, Douglas RG, Bennett JE (eds). New York, Churchill-Livingstone Inc, 3rd Ed, 1990, pp 2291-2294
6. Boumpas DT: Anti-inflammatory and immunosuppressive effects. NIH Conference: Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119:1198-1208
7. Aukrust P, Moum B, Farstad IN, et al: Fatal cytomegalovirus colitis in a patient receiving low dose prednisolone therapy. Scand J Infect Dis 1991; 23:495-499
8. Orloff JJ, Saito R, Lasky S, et al: Toxic megacolon in cytomegalovirus colitis. Am J Gastroenterol 1989; 84:794-797
9. Nishi K, Myoh S, Bandoh T, et al: An autopsy case of dermatomyositis associated with interstitial pneumonia probably due to cytomegalovirus infection. Nippon Kyobu Shikkan Gakkai Zasshi 1992; 30:1975-1980
10. Leong KH, Boey ML, Feng PH: Coexisting Pneumocystis carinii pneumonia, cytomegalovirus pneumonitis and salmonellosis in systemic lupus erythematosus. Ann Rheum Dis 1991; 50:811-812
11. Clerc D, Brousse C, Mariette X, et al: Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone. Ann Rheum Dis 1991; 50:67
12. Hellman DB, Petri M, Whiting-O'Keefe Q: Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 1987; 66:341-348
13. Nived O, Sturfelt G, Wollheim F: Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 1985; 55:271-287
14. Rosenow EC, Myers JL, Swensen SJ, et al: Drug-induced pulmonary disease, an update. Chest 1992; 102:239-250
15. Carson CW, Cannon GW, Egger MJ, et al: Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum 1987; 16:186-195
16. Weiner RS, Horowitz MM, Gale RP, et al: Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anemia. Br J Haematol 1989; 71:535-543
17. Shanley JD, Debs RJ: The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro. Antiviral Res 1989; 11:99-106